Dc Investments Management, LLC Bristol Myers Squibb CO Transaction History

Dc Investments Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $1.3 Million - $1.47 Million	-22,520 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $875,175 - $969,809	15,239 Added 209.3%	22,520 $1.36 Million
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $1.69 Million - $1.98 Million	-30,868 Reduced 80.91%	7,281 $428,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $1.77 Million - $2.57 Million	38,149 New	38,149 $2.13 Million
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $245,222 - $305,641	-4,853 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $290,791 - $334,759	4,853 New	4,853 $307,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.